Laurion Capital Management LP

Position in ABBV — AbbVie Inc.

CIK 1390202 NEW YORK, NY

Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$10,611,155

+$8,785,327 QoQ

Shares Held

42,168

+402.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.80%

of 13F equity value

Holder Rank

#895

of 4,153 holders

Holding Since

Mar 2020

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Sep 30, 2025

CallValue

CallShares

PutValue

$244,274,700

PutShares

1,055,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Laurion Capital Management LP holds $13,138,022 across 6 Drug Manufacturers - General names. ABBV ranks #1 (80.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	42,168	$10,611,155
2	AZN	Astrazeneca PLC	6,000	$1,137,720
3	LLY	ELI LILLY & Co	448	$537,344
4	MRK	Merck & Co., Inc.	3,197	$410,814
5	JNJ	Johnson & Johnson	1,417	$359,875
6	NVO	Novo Nordisk A S	1,692	$81,114

All Filings in ABBV

Export CSV

29 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,611,155	42,168	+402.3%	Shares	Sole	2026-08-13
2026-03-31	$1,825,828	8,395	-71.3%	Shares	Sole	2026-05-14
2025-09-30	$244,274,700	1,055,000	+1218.8%	Put	Sole	2025-11-17
2025-06-30	$126,388,658	680,900	+13.5%	Call	Sole	2025-08-14
2024-06-30	$13,721,600	80,000	-46.7%	Put	Sole	2024-08-14
2024-06-30	$5,020,561	29,271	+225.5%	Shares	Sole	2024-08-14
2024-06-30	$102,912,000	600,000	-21.7%	Call	Sole	2024-08-14
2023-12-31	$1,393,645	8,993	-75.9%	Shares	Sole	2024-02-14
2023-12-31	$118,800,002	766,600	+27.8%	Call	Sole	2024-02-14
2023-09-30	$89,436,000	600,000	0.0%	Call	Sole	2023-11-14
2023-06-30	$80,838,000	600,000	+300.0%	Call	Sole	2023-08-14
2023-03-31	$23,905,500	150,000	-88.7%	Call	Sole	2023-05-15
2023-03-31	$23,905,500	150,000	-85.0%	Put	Sole	2023-05-15
2023-03-31	$5,947,050	37,316	-38.4%	Shares	Sole	2023-05-15
2022-12-31	$161,610,000	1,000,000	+4850.5%	Put	Sole	2023-02-14
2022-09-30	$178,485,879	1,329,900	+280.0%	Call	Sole	2022-11-14
2022-06-30	$53,606,000	350,000	+911.6%	Call	Sole	2022-08-15
2022-03-31	$9,821,596	60,586	-79.1%	Shares	Sole	2022-05-16
2022-03-31	$3,274,622	20,200	-75.5%	Put	Sole	2022-05-16
2021-12-31	$4,684,840	34,600	0.0%	Call	Sole	2022-02-14
2021-12-31	$11,184,040	82,600	-72.1%	Put	Sole	2022-02-14
2021-09-30	$31,276,151	289,943	+852.2%	Shares	Sole	2021-11-15
2021-09-30	$3,732,302	34,600	-95.2%	Call	Sole	2021-11-15
2021-09-30	$31,918,733	295,900	+133.5%	Put	Sole	2021-11-15
2021-06-30	$3,429,888	30,450	-80.4%	Shares	Sole	2021-08-13
2020-12-31	$16,632,358	155,225	+1141.8%	Shares	Sole	2021-02-12
2020-06-30	$1,227,250	12,500	—	Shares	Sole	2020-08-14
2020-03-31	$9,653,273	126,700	—	Put	Sole	2020-05-14
2020-03-31	$54,704,420	718,000	—	Call	Sole	2020-05-14
No filing history on record for this holder in this stock.